Article
Prognostic Factors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor…
Cancer Management and Research · 2021 · Cuyún Carter G, Mohanty M, Stenger K, Morato Guimaraes C, Singuru S, Basa P, Singh S, Tongbram V, Kuemmel S, Guarneri V, Tolaney SM
Key facts
| Title | Prognostic Factors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative (HR+/HER2–) Advanced Breast Cancer: A Systematic Literature Review |
|---|---|
| First author | Cuyún Carter G, Mohanty M, Stenger K, Morato Guimaraes C, Singuru S, Basa P, Singh S, Tongbram V, Kuemmel S, Guarneri V, Tolaney SM |
| Journal | Cancer Management and Research |
| Published | Aug 20, 2021 |
| DOI | 10.2147/CMAR.S300869 |
| Devices mentioned | K160007, K981792, P230043 |
| Product codes mentioned | FPA, PHP |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1